BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30720096)

  • 1. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
    Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
    Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma.
    Zhu J; Zhang J; Hu P; Fan M; Song D; Yin H; Yan P; Xian S; Li Z; Guo J; Long C; Xu R; Huang R; Meng T; Zhang J; Huang Z
    Biochem Genet; 2023 Dec; 61(6):2242-2259. PubMed ID: 37010714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic characterization of cancer genes in glioma.
    Liang A; Zhou B; Sun W
    Cancer Cell Int; 2017; 17():90. PubMed ID: 29046615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's Disease as a Risk Factor for Prostate Adenocarcinoma: A Molecular Point of View.
    Liu T; Yang Z; Liu S; Wei J
    Gerontology; 2023; 69(8):986-1001. PubMed ID: 36921580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontology-based prediction of cancer driver genes.
    Althubaiti S; Karwath A; Dallol A; Noor A; Alkhayyat SS; Alwassia R; Mineta K; Gojobori T; Beggs AD; Schofield PN; Gkoutos GV; Hoehndorf R
    Sci Rep; 2019 Nov; 9(1):17405. PubMed ID: 31757986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic.
    de Schaetzen van Brienen L; Miclotte G; Larmuseau M; Van den Eynden J; Marchal K
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.
    Qiu Z; Lin A; Li K; Lin W; Wang Q; Wei T; Zhu W; Luo P; Zhang J
    Drug Des Devel Ther; 2019; 13():2021-2041. PubMed ID: 31417239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
    La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
    Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma.
    Cai X; Chen Z; Deng M; Li Z; Wu Q; Wei J; Dai C; Wang G; Luo C
    Ann Transl Med; 2020 Sep; 8(18):1176. PubMed ID: 33241025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
    Sailer V; Eng KW; Zhang T; Bareja R; Pisapia DJ; Sigaras A; Bhinder B; Romanel A; Wilkes D; Sticca E; Cyrta J; Rao R; Sahota S; Pauli C; Beg S; Motanagh S; Kossai M; Fontunge J; Puca L; Rennert H; Zhaoying Xiang J; Greco N; Kim R; MacDonald TY; McNary T; Blattner-Johnson M; Schiffman MH; Faltas BM; Greenfield JP; Rickman D; Andreopoulou E; Holcomb K; Vahdat LT; Scherr DS; van Besien K; Barbieri CE; Robinson BD; Fine HA; Ocean AJ; Molina A; Shah MA; Nanus DM; Pan Q; Demichelis F; Tagawa ST; Song W; Mosquera JM; Sboner A; Rubin MA; Elemento O; Beltran H
    JCO Precis Oncol; 2019; 3():. PubMed ID: 31592503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential.
    Hu J; Wang Y; Zhang Y; Yu Y; Chen H; Liu K; Yao M; Wang K; Gu W; Shou T
    Cancer Med; 2019 Aug; 8(9):4338-4347. PubMed ID: 31199602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112.
    van Tran N; Ernst FGM; Hawley BR; Zorbas C; Ulryck N; Hackert P; Bohnsack KE; Bohnsack MT; Jaffrey SR; Graille M; Lafontaine DLJ
    Nucleic Acids Res; 2019 Sep; 47(15):7719-7733. PubMed ID: 31328227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
    Wang H; Shen L; Li Y; Lv J
    J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and catalytic roles of the human 18
    Shen H; Stoute J; Liu KF
    J Biol Chem; 2020 Aug; 295(34):12058-12070. PubMed ID: 32616653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing Analysis Identified Genomic Alterations in Pathological Morphologies of 3 Cases of Pulmonary Carcinosarcoma.
    Li F; Hu S; Kong K; Cao P; Han P; Deng Y; Zhao B
    Onco Targets Ther; 2020; 13():7963-7972. PubMed ID: 32848420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with
    Terzic J; Seipel A; Dubuisson J; Tille JC; Tsantoulis P; Addeo A; Labidi-Galy SI
    Gynecol Oncol Rep; 2020 Aug; 33():100600. PubMed ID: 32613071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation.
    Pauli C; Liu Y; Rohde C; Cui C; Fijalkowska D; Gerloff D; Walter C; Krijgsveld J; Dugas M; Edemir B; Pabst C; Müller LP; Zhou F; Müller-Tidow C
    Blood; 2020 Jun; 135(23):2059-2070. PubMed ID: 32097467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Blood Smears: Qualification of
    Seilie AM; Chang M; Hanron AE; Billman ZP; Stone BC; Zhou K; Olsen TM; Daza G; Ortega J; Cruz KR; Smith N; Healy SA; Neal J; Wallis CK; Shelton L; Mankowski TV; Wong-Madden S; Mikolajczak SA; Vaughan AM; Kappe SHI; Fishbaugher M; Betz W; Kennedy M; Hume JCC; Talley AK; Hoffman SL; Chakravarty S; Sim BKL; Richie TL; Wald A; Plowe CV; Lyke KE; Adams M; Fahle GA; Cowan EP; Duffy PE; Kublin JG; Murphy SC
    Am J Trop Med Hyg; 2019 Jun; 100(6):1466-1476. PubMed ID: 31017084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.